期刊文献+

基于SEER数据库回顾性分析老年结直肠癌伴淋巴结转移患者的预后 被引量:4

A retrospective analysis on prognosis of elderly colorectal cancer patients with lymph node metastasis based on SEER database
下载PDF
导出
摘要 目的探讨影响老年结直肠癌伴淋巴结转移患者预后的相关因素。方法利用SEER*Stat软件筛选监测、流行病学和最终结果(Surveillance,Epidemiology,and End Results,SEER)数据库符合要求的老年结直肠癌伴淋巴结转移患者临床资料,提取包括年龄、性别、检出淋巴结数(examined lymph node,ELN)和阳性淋巴结数(positive lymph node,PLN)等关键变量。通过X-tile软件选取检出ELN、PLN以及肿瘤大小的最佳截断值。利用R及SPSS软件进行单因素及多因素Cox比例风险回归模型分析筛选关键变量。结果 1992~2017年老年患者(≥65岁)在结直肠癌患者中占比虽然逐年降低,但均占>50%。X-tile分析显示,ELN最佳截断值为<12枚、12~17枚及>17枚;PLN最佳截断值为<3枚(低风险组)、3~7枚(中风险组)及>7枚(高风险组);肿瘤大小最佳截断值为<35 mm、35~59 mm及>59 mm。单因素及多因素Cox回归分析显示,种族、原发部位、组织学分型、分级、TNM分期、ELN、PLN以及肿瘤大小均为影响预后的相关因素(均P<0.05),C-Index为0.751。根据PLN分层分析显示,低风险组及中风险组中排除组织学分型为预后影响因素,高风险组中排除肿瘤大小为预后影响因素。结论种族、原发部位、组织学分型、分级、TNM分期、ELN、PLN以及肿瘤大小为影响老年结直肠癌伴淋巴结转移患者预后的相关因素。在不同PLN风险组中影响预后的相关因素存在差异。 Objective To investigate the prognostic factors of elderly patients with colorectal cancer with lymph node metastasis. Methods A SEER*Stat software was used to screen the clinical data of elderly patients with colorectal cancer with lymph node metastasis in the Surveillance, Epidemiology, and End R esults(SEER) database. Key variables including age, sex, examined lymph nodes(ELNs) and positive lymph nodes(PLNs) were included. An X-tile software was used to select the optimal cut-off value of the ELN, PLN and tumor size.Using R and SPSS software, univariate and multivariate Cox proportional hazards regression models were used to analyze and screen the key variables. Results From 1992 to 2017, elderly patients(≥65 years) accounted for the majority(>50%) of patients with colorectal cancer,although the proportion was decreased yearly. The optimal cut-off values of ELN in X-tile analysis were <12, 12-17 and >17. The optimal cut-off values of PLN were <3(low-risk group), 3-7(medium-risk group) and >7(high-risk group). The best cut-off values of tumor size were <35 mm, 35-59 mm and >59 mm. Univariate and multivariate Cox regression analysis showed that race, primary site, histological type, grade, TNM stage, ELN, PLN and tumor size were all related factors affecting prognosis(all P<0.05) with a C-index of 0.751. Selected cases were then stratified according to PLN for following analysis, and the results showed that histological types were excluded in the low-risk and medium-risk groups, and tumor size was excluded in the high-risk group as factors affecting prognosis. Conclusions Race,primary site, histological type, grade, TNM stage, ELN, PLN and tumor size are correlative factors for the prognosis of elderly patients with colorectal cancer with lymph node metastasis. The prognostic factors are different among different PLN risk groups.
作者 杨琴燕 何俊 沈忠 杨关根 Yang Qinyan;He Jun;Shen Zhong;Yang Guangen(Anorectal Department,Hangzhou Third People's Hospital,Hangzhou 310009,China)
出处 《实用肿瘤杂志》 CAS 2022年第1期60-66,共7页 Journal of Practical Oncology
基金 浙江省医药卫生科技计划项目(2020KY721)。
关键词 结直肠癌 老年 预后 淋巴结转移 colorectal cancer elderly prognosis lymph node metastasis
  • 相关文献

参考文献3

二级参考文献64

  • 1Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, RebeloM, Parkin DM, Forman D, Bray F. Cancer incidence and mortalityworldwide: sources, methods and major patterns in GLOBOCAN2012. Int J Cancer 2015; 136: E359-E386 [PMID: 25220842 DOI:10.1002/ijc.29210].
  • 2Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Prediction ofcancer incidence and mortality in Korea, 2014. Cancer Res Treat 2014;46: 124-130 [PMID: 24851103 DOI: 10.4143/crt.2014.46.2.124].
  • 3van Steenbergen LN, Elferink MA, Krijnen P, Lemmens VE,Siesling S, Rutten HJ, Richel DJ, Karim-Kos HE, Coebergh JW.Improved survival of colon cancer due to improved treatment anddetection: a nationwide population-based study in The Netherlands1989-2006. Ann Oncol 2010; 21: 2206-2212 [PMID: 20439339DOI: 10.1093/annonc/mdq227].
  • 4Quaglia A, Tavilla A, Shack L, Brenner H, Janssen-Heijnen M,Allemani C, Colonna M, Grande E, Grosclaude P, Vercelli M. Thecancer survival gap between elderly and middle-aged patients inEurope is widening. Eur J Cancer 2009; 45: 1006-1016 [PMID:19121578 DOI: 10.1016/j.ejca.2008.11.028].
  • 5Surgery for colorectal cancer in elderly patients: a systematicreview. Colorectal Cancer Collaborative Group. Lancet 2000; 356:968-974 [PMID: 11041397 DOI: 10.1016/S0140-6736(00)02713-6].
  • 6Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age,sex, and racial differences in the use of standard adjuvant therapyfor colorectal cancer. J Clin Oncol 2002; 20: 1192-1202 [PMID:11870160].
  • 7Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF,Neugut AI. Survival associated with 5-fluorouracil-based adjuvantchemotherapy among elderly patients with node-positive coloncancer. Ann Intern Med 2002; 136: 349-357 [PMID: 11874307DOI: 10.7326/0003-4819-136-5-200203050-00007].
  • 8Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvantchemotherapy use after surgery for stage III colon cancer. J NatlCancer Inst 2001; 93: 850-857 [PMID: 11390534 DOI: 10.1093/jnci/93.11.850].
  • 9Aparicio T, Navazesh A, Boutron I, Bouarioua N, Chosidow D,Mion M, Choudat L, Sobhani I, Mentré F, Soulé JC. Half of elderlypatients routinely treated for colorectal cancer receive a substandardtreatment. Crit Rev Oncol Hematol 2009; 71: 249-257[PMID: 19131256 DOI: 10.1016/j.critrevonc.2008.11.006].
  • 10van Erning FN, van Steenbergen LN, Lemmens VE, Rutten HJ,Martijn H, van Spronsen DJ, Janssen-Heijnen ML. Conditionalsurvival for long-term colorectal cancer survivors in theNetherlands: who do best- Eur J Cancer 2014; 50: 1731-1739[PMID: 24814358 DOI: 10.1016/j.ejca.2014.04.009].

共引文献64

同被引文献32

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部